Exceptional charges of Rs 1,268.8 crore, including a US antitrust settlement and Organon acquisition costs, weighed on profit, while India formulation sales grew 17.3 per cent
The post Sun Pharma Q2 net profit falls 36% on one-time charges, revenue rises 12% appeared first on Home Page.
